Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Jonathan L. Robbins, Kathryn Bonuck, Philippe Thuillier, Catriona Buist & Patricia A. Carney. (2022) Differences in perceived clinical knowledge uptake among health profession students and licensed clinicians receiving buprenorphine waiver training in Oregon . Substance Abuse 43:1, pages 825-833.
Read now
Read now
Lydia Aletraris, Mary Bond Edmond, Maria Paino, Dail Fields & Paul M. Roman. (2016) Counselor training and attitudes toward pharmacotherapies for opioid use disorder. Substance Abuse 37:1, pages 47-53.
Read now
Read now
Amy Wachholtz, Gerardo Gonzalez, Edward Boyer, Zafar N Naqvi, Christopher Rosenbaum & Douglas Ziedonis. (2011) Intersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies. Substance Abuse and Rehabilitation 2, pages 145-162.
Read now
Read now
Amy Wachholtz, Douglas Ziedonis & Gerardo Gonzalez. (2011) Comorbid Pain and Opioid Addiction: Psychosocial and Pharmacological Treatments. Substance Use & Misuse 46:12, pages 1536-1552.
Read now
Read now
David Hersh, Sherri
L. Little & Alice Gleghorn. (2011) Integrating Buprenorphine Treatment into a Public Healthcare System: The San Francisco Department of Public Health's Office-Based Buprenorphine Pilot Program. Journal of Psychoactive Drugs 43:2, pages 136-145.
Read now
Read now
Traci Rieckmann, AnneE. Kovas & BethA. Rutkowski. (2010) Adoption of Medications in Substance Abuse Treatment: Priorities and Strategies of Single State Authorities. Journal of Psychoactive Drugs 42:sup6, pages 227-238.
Read now
Read now
Ryan K. Schwarz, R. Douglas Bruce, Samuel A. Ball, Maua Herme & Frederick L. Altice. (2009) Comparison of Tuberculin Skin Testing Reactivity in Opioid-Dependent Patients Seeking Treatment with Methadone versus Buprenorphine: Policy Implications for Tuberculosis Screening. The American Journal of Drug and Alcohol Abuse 35:6, pages 439-444.
Read now
Read now
Angela L Stotts, Carrie L Dodrill & Thomas R Kosten. (2009) Opioid dependence treatment: options in pharmacotherapy. Expert Opinion on Pharmacotherapy 10:11, pages 1727-1740.
Read now
Read now
David A. Fiellin, Brent A. Moore, Lynn E. Sullivan, William C. Becker, Michael V. Pantalon, Marek C. Chawarski, Declan T. Barry, Patrick G. O'Connor & Richard S. Schottenfeld. (2008) Long-Term Treatment with Buprenorphine/Naloxone in Primary Care: Results at 2–5 Years. American Journal on Addictions 17:2, pages 116-120.
Read now
Read now
Sabine Loeber, Anja Kniest, Alexander Diehl, Karl Mann & Bernhard Croissant. (2008) Neuropsychological Functioning of Opiate-Dependent Patients: A Nonrandomized Comparison of Patients Preferring either Buprenorphine or Methadone Maintenance Treatment. The American Journal of Drug and Alcohol Abuse 34:5, pages 584-593.
Read now
Read now
WilliamC. Becker & DavidA. Fiellin. (2006) Provider Satisfaction with Office-Based Treatment of Opioid Dependence. Substance Abuse 26:1, pages 15-22.
Read now
Read now
David A. Fiellin, Patrick G. O'Connor, Marek Chawarski & Richard S. Schottenfeld. (2004) Processes of Care During a Randomized Trial of Office-based Treatment of Opioid Dependence in Primary Care. American Journal on Addictions 13:sup1, pages S67-S78.
Read now
Read now
DavidA. Fiellin, RobertA. Rosenheck & ThomasR. Kosten. (2003) Coordination of medical care and opioid dependence treatment in primary care: A case report. Substance Abuse 24:1, pages 43-46.
Read now
Read now
JeffreyG. Wong, MarkL. Kraus, MichaelA. Feinberg & DavidA. Fiellin. (2003) Editorial. Substance Abuse 24:1, pages 1-3.
Read now
Read now
Articles from other publishers (56)
Babak Tofighi, Christina Marini, Joshua D. Lee & Eric L. Garland. (2023) Patient Perceptions of Integrating Meditation-based Interventions in Office-based Opioid Treatment with Buprenorphine: A Mixed-methods Survey. Journal of Addiction Medicine Publish Ahead of Print.
Crossref
Crossref
Lamia Y. Haque & David A. Fiellin. (2022) Bridging the Gap: Dual Fellowship Training in Addiction Medicine and Digestive Diseases. Digestive Diseases and Sciences 67:7, pages 2721-2726.
Crossref
Crossref
Tiffany Lu & Chinazo Cunningham. 2021. Treating Opioid Use Disorder in General Medical Settings. Treating Opioid Use Disorder in General Medical Settings
23
42
.
Joseph H. Donroe, Elenore P. Bhatraju, Judith I. Tsui & E. Jennifer Edelman. (2020) Identification and Management of Opioid Use Disorder in Primary Care: an Update. Current Psychiatry Reports 22:5.
Crossref
Crossref
Lisa de Saxe Zerden, Ting Guan, Brianna M. Lombardi, Anjalee Sharma & Yazmin Garcia-Rico. (2020) Psychosocial Interventions in Office-Based Opioid Treatment: A Systematic Review. Journal of the Society for Social Work and Research 11:1, pages 103-131.
Crossref
Crossref
Lara L. Nixon, Jazmin C. Marlinga, K. Alix Hayden & Kelly J. Mrklas. (2019) Barriers and facilitators to office-based opioid agonist therapy prescribing and effective interventions to increase provider prescribing: protocol for a systematic review. Systematic Reviews 8:1.
Crossref
Crossref
Jennifer R. Havens, Sharon L. Walsh, P. Todd Korthuis & David A. Fiellin. (2018) Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and Treatment. Current HIV/AIDS Reports 15:4, pages 315-323.
Crossref
Crossref
Stephanie Lee Peglow & Ingrid A. Binswanger. (2018) Preventing Opioid Overdose in the Clinic and Hospital. Medical Clinics of North America 102:4, pages 621-634.
Crossref
Crossref
Dennis McCarty, Kelsey C. Priest & P. Todd Korthuis. (2018) Treatment and Prevention of Opioid Use Disorder: Challenges and Opportunities. Annual Review of Public Health 39:1, pages 525-541.
Crossref
Crossref
Pooja Lagisetty, Katarzyna Klasa, Christopher Bush, Michele Heisler, Vineet Chopra & Amy Bohnert. (2017) Primary care models for treating opioid use disorders: What actually works? A systematic review. PLOS ONE 12:10, pages e0186315.
Crossref
Crossref
Elizabeth A. Mayerson & Thomas Julian. (2017) Acute Pain Management for Patients on Medication-Assisted Treatment for Opioid-Use Disorder. Topics in Pain Management 33:3, pages 1-10.
Crossref
Crossref
Traci R. Rieckmann, Nicholas Gideonse, Amanda Risser, Jennifer E. DeVoe & Amanda J. Abraham. (2017) Treating Opioid Dependence with Buprenorphine in the Safety Net: Critical Learning from Clinical Data. The Journal of Behavioral Health Services & Research 44:3, pages 351-363.
Crossref
Crossref
Michael D. Stein, Debra S. Herman, Ethan Moitra, Jacki Hecht, Rosalie Lopez, Bradley J. Anderson & Richard A. Brown. (2015) A preliminary randomized controlled trial of a distress tolerance treatment for opioid dependent persons initiating buprenorphine. Drug and Alcohol Dependence 147, pages 243-250.
Crossref
Crossref
Richard A. Brown, Erika Litvin Bloom, Jacki Hecht, Ethan Moitra, Debra S. Herman & Michael D. Stein. (2014) A Pilot Study of a Distress Tolerance Treatment for Opiate-Dependent Patients Initiating Buprenorphine. Behavior Modification 38:5, pages 730-759.
Crossref
Crossref
Traci R. Rieckmann, Amanda J. Abraham, Anne E. Kovas, Bentson H. McFarland & Paul M. Roman. (2014) Impact of research network participation on the adoption of buprenorphine for substance abuse treatment. Addictive Behaviors 39:5, pages 889-896.
Crossref
Crossref
Karen L. Cropsey, Peter S. Lane, Adam C. Perkins, C. Brendan Clark, Sonya Hardy, C. McCullumsmith & Maxine L. Stitzer. (2013) Buprenorphine and Medication Management in a Community Corrections Population. Journal of Addiction Medicine 7:3, pages 210-215.
Crossref
Crossref
David A. Fiellin, Declan T. Barry, Lynn E. Sullivan, Christopher J. Cutter, Brent A. Moore, Patrick G. O'Connor & Richard S. Schottenfeld. (2013) A Randomized Trial of Cognitive Behavioral Therapy in Primary Care-based Buprenorphine. The American Journal of Medicine 126:1, pages 74.e11-74.e17.
Crossref
Crossref
Jeanette M. Tetrault, Brent A. Moore, Declan T. Barry, Patrick G. O'Connor, Richard Schottenfeld, David A. Fiellin & Lynn E. Fiellin. (2012) Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients. Journal of Substance Abuse Treatment 43:4, pages 433-439.
Crossref
Crossref
Traci R. Rieckmann, Anne E. Kovas, Bentson H. McFarland & Amanda J. Abraham. (2011) A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment. Journal of Substance Abuse Treatment 41:4, pages 374-385.
Crossref
Crossref
Julie Netherland. 2011. Sociological Reflections on the Neurosciences. Sociological Reflections on the Neurosciences
153
177
.
Frederick L Altice, R Douglas Bruce, Gregory M Lucas, Paula J Lum, P Todd Korthuis, Timothy P Flanigan, Chinazo O Cunningham, Lynn E Sullivan, Pamela Vergara-Rodriguez, David A Fiellin, Adan Cajina, Michael Botsko, Vijay Nandi, Marc N Gourevitch & Ruth Finkelstein. (2011) HIV Treatment Outcomes Among HIV-Infected, Opioid-Dependent Patients Receiving Buprenorphine/Naloxone Treatment within HIV Clinical Care Settings: Results From a Multisite Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 56:Supplement 1, pages S22-S32.
Crossref
Crossref
P. Todd Korthuis, Jessica Gregg, Wendy E. Rogers, Dennis McCarty, Christina Nicolaidis & Joshua Boverman. (2010) Patients' Reasons for Choosing Office-Based Buprenorphine: Preference for Patient-Centered Care. Journal of Addiction Medicine 4:4, pages 204-210.
Crossref
Crossref
Patrizia Amato. (2010) Clinical Experience with Fortnightly Buprenorphine/Naloxone versus Buprenorphine in Italy. Clinical Drug Investigation 30, pages 33-39.
Crossref
Crossref
Roger D. Weiss, Jennifer S. Potter, Marc L. Copersino, Kristi Prather, Petra Jacobs, Scott Provost, David Chim, Jeffrey Selzer & Walter Ling. (2010) Conducting Clinical Research with Prescription Opioid Dependence: Defining the Population. The American Journal on Addictions 19:2, pages 141-146.
Crossref
Crossref
Nancy L. Sohler, Xuan Li, Hillary V. Kunins, Galit Sacajiu, Angela Giovanniello, Susan Whitley & Chinazo O. Cunningham. (2010) Home- versus office-based buprenorphine inductions for opioid-dependent patients. Journal of Substance Abuse Treatment 38:2, pages 153-159.
Crossref
Crossref
Roger D. Weiss, Jennifer Sharpe Potter, Scott E. Provost, Zhen Huang, Petra Jacobs, Albert Hasson, Robert Lindblad, Hilary Smith Connery, Kristi Prather & Walter Ling. (2010) A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, design, and methodology. Contemporary Clinical Trials 31:2, pages 189-199.
Crossref
Crossref
Lynn E. Sullivan, Brent A. Moore, Patrick G. O'Connor, Declan T. Barry, Marek C. Chawarski, Richard S. Schottenfeld & David A. Fiellin. (2009) The Association between Cocaine Use and Treatment Outcomes in Patients Receiving Office‐Based Buprenorphine/Naloxone for the Treatment of Opioid Dependence. The American Journal on Addictions 19:1, pages 53-58.
Crossref
Crossref
Hassan Shams Esfandabad, Samira Nejadnaderi & Susan Emamipour. (2010) Assessment of quality of life and psychological disorder symptoms among opium - dependent men on buprenorphine detoxification. Procedia - Social and Behavioral Sciences 5, pages 1396-1399.
Crossref
Crossref
T.V. Parran, C.A. Adelman, B. Merkin, M.E. Pagano, R. Defranco, R.A. Ionescu & A.G. Mace. (2010) Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy. Drug and Alcohol Dependence 106:1, pages 56-60.
Crossref
Crossref
Gerardo González & Mauricio Romero-González. (2010) Alternativas farmacológicas para el tratamiento de la dependencia a la heroína: un nuevo reto en Colombia. Revista Colombiana de Psiquiatría 39, pages 188S-212S.
Crossref
Crossref
Julie Netherland, Michael Botsko, James E. Egan, Andrew J. Saxon, Chinazo O. Cunningham, Ruth Finkelstein, Mark N. Gourevitch, John A. Renner, Nancy Sohler, Lynn E. Sullivan, Linda Weiss & David A. Fiellin. (2009) Factors affecting willingness to provide buprenorphine treatment. Journal of Substance Abuse Treatment 36:3, pages 244-251.
Crossref
Crossref
Declan T. Barry, Kevin S. Irwin, Emlyn S. Jones, William C. Becker, Jeanette M. Tetrault, Lynn E. Sullivan, Helena Hansen, Patrick G. O’Connor, Richard S. Schottenfeld & David A. Fiellin. (2008) Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative Study. Journal of General Internal Medicine 24:2, pages 218-225.
Crossref
Crossref
Lynn E. Sullivan, Brent A. Moore, Marek C. Chawarski, Michael V. Pantalon, Declan Barry, Patrick G. O'Connor, Richard S. Schottenfeld & David A. Fiellin. (2008) Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors. Journal of Substance Abuse Treatment 35:1, pages 87-92.
Crossref
Crossref
Leslie L. Buckley, Nicholas Seivewright, Mark Parry, Abhijeetha Salvaji & Richard Schottenfeld. 2010. Cambridge Textbook of Effective Treatments in Psychiatry. Cambridge Textbook of Effective Treatments in Psychiatry
381
401
.
Brent A. Moore, David A. Fiellin, Declan T. Barry, Lynn E. Sullivan, Marek C. Chawarski, Patrick G. O’Connor & Richard S. Schottenfeld. (2007) Primary Care Office-based Buprenorphine Treatment: Comparison of Heroin and Prescription Opioid Dependent Patients. Journal of General Internal Medicine 22:4, pages 527-530.
Crossref
Crossref
Frank J. Vocci. 2007. Handbook of Contemporary Neuropharmacology. Handbook of Contemporary Neuropharmacology.
Declan T. Barry, Brent A. Moore, Michael V. Pantalon, Marek C. Chawarski, Lynn E. Sullivan, Patrick G. O’Connor, Richard S. Schottenfeld & David A. Fiellin. (2007) Patient Satisfaction with Primary Care Office-Based Buprenorphine/Naloxone Treatment. Journal of General Internal Medicine 22:2, pages 242-245.
Crossref
Crossref
R. Douglas Bruce, Duncan Smith-Rohrberg & Frederick L. Altice. 2007. Public Health Behind Bars. Public Health Behind Bars
385
411
.
Lynn E. Sullivan, Robert D. Bruce, David Haltiwanger, Gregory M. Lucas, Lois Eldred, Ruth Finkelstein & David A. Fiellin. (2006) Initial Strategies for Integrating Buprenorphine into HIV Care Settings in the United States. Clinical Infectious Diseases 43:Supplement_4, pages S191-S196.
Crossref
Crossref
Lynn E. Sullivan, Declan Barry, Brent A. Moore, Marek C. Chawarski, Jeanette M. Tetrault, Michael V. Pantalon, Patrick G. O'Connor, Richard S. Schottenfeld & David A. Fiellin. (2006) A Trial of Integrated Buprenorphine/Naloxone and HIV Clinical Care. Clinical Infectious Diseases 43:Supplement_4, pages S184-S190.
Crossref
Crossref
Frederick L. Altice, Lynn E. Sullivan, Duncan Smith-Rohrberg, Sanjay Basu, Sharon Stancliff & Lois Eldred. (2006) The Potential Role of Buprenorphine in the Treatment of Opioid Dependence in HIV-Infected Individuals and in HIV Infection Prevention. Clinical Infectious Diseases 43:Supplement_4, pages S178-S183.
Crossref
Crossref
Christian Haasen & Wim van den Brink. (2006) Innovations in agonist maintenance treatment of opioid-dependent patients. Current Opinion in Psychiatry 19:6, pages 631-636.
Crossref
Crossref
Wim van den Brink & Christian Haasen. (2006) Evidence-Based Treatment of Opioid-Dependent Patients. The Canadian Journal of Psychiatry 51:10, pages 635-646.
Crossref
Crossref
David A. Fiellin, Michael V. Pantalon, Marek C. Chawarski, Brent A. Moore, Lynn E. Sullivan, Patrick G. O'Connor & Richard S. Schottenfeld. (2006) Counseling plus Buprenorphine–Naloxone Maintenance Therapy for Opioid Dependence. New England Journal of Medicine 355:4, pages 365-374.
Crossref
Crossref
Kuo‐Sheng Liu, Ching‐Nan Lin, Ja‐Ping Shieh, Chin‐Chen Chu, Chun‐Hsiung Kuei & Jhi‐Joung Wang. (2006) The novel depot of buprenorphine propionate has a long‐acting effect on physical dependence on morphine. Drug Development Research 67:5, pages 462-469.
Crossref
Crossref
L. E. Sullivan & D. A. Fiellin. (2005) Buprenorphine: Its Role in Preventing HIV Transmission and Improving the Care of HIV-Infected Patients with Opioid Dependence. Clinical Infectious Diseases 41:6, pages 891-896.
Crossref
Crossref
Lynn E. Sullivan, David S. Metzger, Paul J. Fudala & David A. Fiellin. (2005) Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. Addiction 100:2, pages 150-158.
Crossref
Crossref
David A. Fiellin, Herbert Kleber, Jeanne G. Trumble-Hejduk, A. Thomas McLellan & Thomas R. Kosten. (2004) Consensus statement on office-based treatment of opioid dependence using buprenorphine. Journal of Substance Abuse Treatment 27:2, pages 153-159.
Crossref
Crossref
Michael V. Pantalon, David A. Fiellin, Patrick G. O’Connor, Marek C. Chawarski, Juliana R. Pakes & Richard S. Schottenfeld. (2004) Counseling Requirements for Buprenorphine Maintenance in Primary Care. Addictive Disorders & Their Treatment 3:2, pages 71-76.
Crossref
Crossref
Marc Galanter, Helen Dermatis, Linda Glickman, Robert Maslansky, M.Brealyn Sellers, Erna Neumann & Claudia Rahman-Dujarric. (2004) Network therapy: Decreased secondary opioid use during buprenorphine maintenance. Journal of Substance Abuse Treatment 26:4, pages 313-318.
Crossref
Crossref
Duncan Smith-Rohrberg, R. Douglas Bruce & Frederick L. Altice. (2016) Research Note — Review of Corrections-Based Therapy for Opiate-Dependent Patients: Implications for Buprenorphine Treatment among Correctional Populations. Journal of Drug Issues 34:2, pages 451-480.
Crossref
Crossref
Wim van den Brink & Jan M. van Ree. (2003) Pharmacological treatments for heroin and cocaine addiction. European Neuropsychopharmacology 13:6, pages 476-487.
Crossref
Crossref
Wim van den Brink, Marian Goppel & Jan M. van Ree. (2003) Management of opioid dependence. Current Opinion in Psychiatry 16:3, pages 297-304.
Crossref
Crossref
Wim van den Brink, Marian Goppel & Jan van Ree. (2003) Current Opinion in Psychiatry 16:3, pages 297-304.
Crossref
Crossref
. (2003) Office-Based Treatment of Opioid-Dependent Patients. New England Journal of Medicine 348:1, pages 81-82.
Crossref
Crossref
David A. Fiellin & Patrick G. O'Connor. (2002) Office-Based Treatment of Opioid-Dependent Patients. New England Journal of Medicine 347:11, pages 817-823.
Crossref
Crossref